Headache induced by chronic overuse of antimigraine drugs and antalgesics;Céphalées induites par abus des traitements symptomatiques antalgiques et antimigraineux

Revue Neurologique

Volumn 157, Issue 10, 2001, Pages 1221-1234

  Taimi C ^a   Navez, M ^a   Perrin, A M ^a   Laurent, B ^a  

^a CENTRE HOSPITALIER DE ROANNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIMIGRAINE AGENT; BARBITURIC ACID DERIVATIVE; CODEINE; DEXTROPROPOXYPHENE; ERGOTAMINE; METHYSERGIDE; MUSCLE RELAXANT AGENT; NAPROXEN; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PYRAZOLONE; SEDATIVE AGENT; SUMATRIPTAN; TRAMADOL; TRANQUILIZER; ZOLMITRIPTAN;

CHRONICITY; CLINICAL PROTOCOL; DISEASE CLASSIFICATION; DRUG ABUSE; HEADACHE; HEALTH CARE COST; HUMAN; MIGRAINE; PATHOPHYSIOLOGY; PROGNOSIS; REBOUND; RELAPSE; REVIEW;

ANALGESICS; ERGOTAMINES; FOLLOW-UP STUDIES; HEADACHE; HUMANS; MIGRAINE DISORDERS; PATIENT EDUCATION; SEROTONIN AGONISTS; SUBSTANCE-RELATED DISORDERS;

EID: 0035160276     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Drug abuse headache: Recognition and management
2. Long term prognosis of analgesic withdrawal in patients with drug-induced headache
3. Céphalées quotidiennes chroniques
4. The association between analgesic abuse and headache - Coincidental or causal. Letters to the editors
5. Sumatriptan and daily headache
6. Simultaneous activation of spinal antiopioid system (neuropeptide FF) and pain facilitatory circuitry by stimulation of opioid receptors in rats
7. Céphalées des antalgiques
8. Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache
9. Headache associated with chronic use of substances
10. Drug abuse and headache
11. The impact of ergotamine-induced headache and ergotamine withdrawal on information processing
12. Endogenous pain control mechanisms
13. Inappropriate use of sumatriptan: Population based register and interview study
14. Sumatriptan is not the only analgesic used inappropriately
15. Easy therapeutical management of sumatriptan-induced daily headache
16. The use of methylergonovine (Methergine*) in the initial control of drug-induced refractory headache
17. Céphalées, névralgies crâniennes, douleurs de la face, classification et critères diagnostiques
18. Les céphalées de tension: Description clinique et place nosologique
19. Aspects psychologiques des migraines et des céphalées
20. Abrupt outpatient withdrawal of medication in analgesic abusing migraineurs
21. 5 HT in migraine patients with medication-induced headache
22. Possible pharmalogical mechanisms of chronic abuse of analgesics and other antimigraine drugs
23. Sumatriptan
24. A comparative study of iatrogenesis, medication abuse, and psychiatric morbidity in chronic pain patients with and without medically explaned symptoms
25. Does analgesic abuse cause headaches de novo? Letters to the editors
26. Opiate tolerance to daily heroin administration: An apparent phenomenon associated with enhanced pain sensitivity
27. Evaluation des facteurs psychologiques liés aux céphalées de tension: Revue des instruments psychométriques
28. Headache after frequent use of serotonin agonists zolmitriptan and naratriptan
29. Malpractrice risks associated with prescribing medication for chronic headache
30. Amelioration of ergotamine withdrawal symptoms with naproxen
31. Chronic refractory headache
32. Transformed migraine, analgesic rebound and other chronic daily headaches
33. Medication misuse headache
34. Transformation of episodic migraine into daily headache: Analysis of factors
35. Drug induced refractory headache-clinical features and management
36. Hypothalamic activation in cluster headache attacks
37. Functional magnetic resonance imaging in spontaneous attacks of SUNCT: Short-lasting neuralgiform headache with conjunctival injection and tearing
38. Céphalées induites par les antalgiques et les médicaments de l'accès migraineux
39. Clinical and pathophysiological observations in migraine and tension-type headache explained by integration of vascular, supraspinal and myofascial inputs
40. Analgesic headache
41. Is there a problem with long term use of sumatriptan in acute migraine?
42. Headaches associated with chronic use of analgesics: A therapeutic approach
43. Does chronic use of sumatriptan induce dependence?
44. Shared mechanisms in affective illness, epilepsy and migraine
45. Analgesic rebound headache in clinical practice: Data from a physician survey
46. Treatment of status migrainosus: The american experience
47. Interrelations beetween migraine and tension-type headache in the general population
48. Céphalées chroniques par abus de médicaments: Danger pour le migraineux. Schweiz
49. Role and impact of over-the-counter medication in the management of headache
50. MMPI and critical flicker frequency (CFF) analysis in headache patients with and without drug abuse
51. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: Five-year follow-up
52. Analgegic rebound headache. How great is the problem and what can be done
53. Classification of daily and near daily headaches: Field trial of revised IHS criteria
54. Clinical features of chronic daily headache
55. A derangement of serotonin system in migrainous patients with analgesic abuse headache: Clues from platelets
56. Drug-induced headache: Long-term results of stationary versus ambulatory withdrawal therapy
57. Céphalées psychogènes
58. Céphalées de tension
59. Psychologie des céphalalgiques. Petite contribution au grand chambardement
60. Analgesic rebound headache: Experience in a community hospital
61. Medication-induced headache: Overview and systematic review of therapeutic approaches